NCT04818918View on ClinicalTrials.gov

Coronary Flow and Myocardial Viability: the FloVITA Study

RecruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

May 19, 2021

Primary Completion Date

August 20, 2024

Study Completion Date

August 20, 2024

Conditions
Myocardial InfarctionMyocardial Ischemia
Interventions
DEVICE

Absolute coronary flow measurement

Absolute coronary flow will be measured.

DEVICE

Microvascular resistance measurement

Microvascular resistance will be measured.

OTHER

Cardiac MRI

Cardiac MRI will be performed to evaluate myocardial viability.

Trial Locations (1)

25000

RECRUITING

CHU Besancon, Besançon

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER